Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

87239-81-4 - Cefpodoxime proxetil, 96% - J66061 - Alfa Aesar

J66061 Cefpodoxime proxetil, 96%

CAS-Nummer
87239-81-4
Synonyme

Größe Preis ($) Menge Verfügbarkeit
1g 241,00
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

Cefpodoxime proxetil, 96%

MDL
MFCD00865088

Chemische Eigenschaften

Formel
C21H27N5O9S2
Molmasse
557.60
Form
Powder
Schmelzpunkt
111-113°
Sensitivität
Light Sensitive
Löslichkeit
Soluble in DMSO

Anwendungen

A broad spectrum antibiotic. Cefpodoxime proxetil is commonly used in clinical in vitro microbiological antimicrobial susceptibility tests (panels, discs, and MIC strips) against gram positive and gram negative microbial isolates. Medical microbiologists use AST results to recommend antibiotic treatment options for infected patients. Product is to be used for research and development only.

Bemerkungen

Research Use only: Not intended for animal or human diagnostic or therapeutic use.

Like β-lactams, cephalosporins interfere with PBP (penicillin binding protein) activity involved in the final phase of peptidoglycan synthesis. PBP’s are enzymes which catalyze a pentaglycine crosslink between alanine and lysine residues providing additional strength to the cell wall. Without a pentaglycine crosslink, the integrity of the cell wall is severely compromised and ultimately leads to cell lysis and death. Resistance to cephalosporins is commonly due to cells containing plasmid encoded β-lactamases. However, like many cephalosporins, cefpodoxime is stable in the presence of β-lactamases.

Cefpodoxime proxetil is a broad spectrum antibiotic which targets a wide variety of gram positive and gram negative bacteria especially those which cause otitis media and pharyngitis.

Literaturverweise

Georgopapadakou, N. H. Mechanisms of Action of Cephalosporin 3'- quinolone Esters, Carbamates, and Tertiary Amines in Escherichia Coli. American Society for Microbiology 1992, 37.3, 559-565.

GHS Gefahren- und Sicherheitshinweise

Gefahrenhinweise (EU): H334-H317

May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction.

Sicherheitshinweise: P284-P261-P280g-P342+P311a-P363-P501a

Wear respiratory protection. Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves. If experiencing respiratory symptoms: Wash contaminated clothing before reuse. Dispose of contents/container in accordance with local/regional/national/international regulations.

Weitere Referenzen

Harmonized Tariff Code
2941.90
TSCA
No
RTECS
XI0367370

Empfohlen

  • A15695

    Methyl o-toluate, 99%
  • 10417

    Tungsten foil, 0.05mm (0.002in) thick, 99.95% (metals basis)
  • H52321

    4-[2-(4-Nitrophenoxy)ethyl]morpholine, 96%
  • A16655

    (S)-(+)-N-(3,5-Dinitrobenzoyl)-1-phenylethylamine, 98%
  • H62450

    (S)-4-Amino-2-(Boc-amino)butyric acid, 97%

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf